We are live on
!
Find out more
BA
BlackRock Advisors Portfolio holdings
AUM
$98.8B
1-Year Est. Return
15.8%
This Fund
S&P 500
This Quarter
Est. Return
-7.26%
1 Year Est. Return
+15.8%
3 Year Est. Return
+32.35%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$93.3B
AUM Growth
-$2.89B
(-3%)
Cap. Flow
+$5.74B
Cap. Flow
% of AUM
6.15%
Top 10 Holdings %
Top 10 Hldgs %
15.28%
Holding
3,878
New
163
Increased
1,568
Reduced
1,679
Closed
111
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$423M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$367M |
| 3 |
ExxonMobil
XOM
|
+$337M |
| 4 |
Johnson & Johnson
JNJ
|
+$257M |
| 5 |
Biogen
BIIB
|
+$250M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$195M |
| 2 |
AbbVie
ABBV
|
+$188M |
| 3 |
JPMorgan Chase
JPM
|
+$183M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$176M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.49% |
| 2 | Financials | 16.75% |
| 3 | Technology | 9.99% |
| 4 | Industrials | 8.32% |
| 5 | Energy | 7.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
Guidewire Software
GWRE
$13.2B
| $3.35M | ﹤0.01% |
63,643
+17,894
| +39% | +$990K |
|
1202
LXP Industrial Trust
LXP
$3.53B
| $3.33M | ﹤0.01% |
82,294
-13,036
| -14% | -$550K |
|
1203
O-I Glass
OI
$1.42B
| $3.33M | ﹤0.01% |
160,747
+18,178
| +13% | +$386K |
|
1204
Scorpio Tankers
STNG
$3.95B
| $3.33M | ﹤0.01% |
36,262
+27,240
| +302% | +$2.73M |
|
1205
World Kinect Corp
WKC
$2.07B
| $3.3M | ﹤0.01% |
92,231
+81,402
| +752% | +$3.39M |
|
|
TBI
1206
Trueblue
TBI
$238M
| $3.3M | ﹤0.01% |
146,687
-38,650
| -21% | -$991K |
|
1207
Box
BOX
$4.38B
| $3.29M | ﹤0.01% |
261,122
+254,697
| +3,964% | +$3.79M |
|
1208
Hyster-Yale Materials Handling
HY
$618M
| $3.27M | ﹤0.01% |
56,623
-3,953
| -7% | -$252K |
|
|
XOXO
1209
DELISTED
Xo Group Inc
XOXO
| $3.27M | ﹤0.01% |
231,712
+185,590
| +402% | +$2.79M |
|
1210
New Jersey Resources
NJR
$6.1B
| $3.27M | ﹤0.01% |
108,747
-727
| -0.7% | -$20.7K |
|
|
NFX
1211
DELISTED
Newfield Exploration
NFX
| $3.26M | ﹤0.01% |
99,066
+19,913
| +25% | +$668K |
|
1212
Core Laboratories
CLB
$497M
| $3.22M | ﹤0.01% |
32,277
+25,819
| +400% | +$2.81M |
|
1213
Boyd Gaming
BYD
$6.78B
| $3.21M | ﹤0.01% |
196,893
+142,554
| +262% | +$2.36M |
|
|
MNDT
1214
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $3.18M | ﹤0.01% |
99,856
+94,790
| +1,871% | +$3.96M |
|
|
AM
1215
DELISTED
ANTERO MIDSTREAM PARTNERS LP
AM
| $3.18M | ﹤0.01% |
177,880
-1,850
| -1% | -$44K |
|
1216
Tyler Technologies
TYL
$13.8B
| $3.17M | ﹤0.01% |
21,264
-716
| -3% | -$101K |
|
1217
Lesaka Technologies
LSAK
$393M
| $3.15M | ﹤0.01% |
188,184
-6,680
| -3% | -$127K |
|
|
SPR
1218
DELISTED
Spirit AeroSystems
SPR
| $3.15M | ﹤0.01% |
65,118
-137,736
| -68% | -$7.33M |
|
|
GOLD
1219
DELISTED
Randgold Resources Ltd
GOLD
| $3.15M | ﹤0.01% |
53,624
+3,926
| +8% | +$237K |
|
|
DNB
1220
DELISTED
Dun & Bradstreet
DNB
| $3.15M | ﹤0.01% |
29,956
+29,562
| +7,503% | +$3.38M |
|
1221
Energy Transfer Partners
ET
$69.2B
| $3.13M | ﹤0.01% |
150,420
+620
| +0.4% | +$17.5K |
|
1222
Infosys
INFY
$49.9B
| $3.13M | ﹤0.01% |
327,420
-253,592
| -44% | -$2.17M |
|
|
N
1223
DELISTED
Netsuite Inc
N
| $3.12M | ﹤0.01% |
37,165
+31,873
| +602% | +$2.93M |
|
1224
iShares MSCI Global Min Vol Factor ETF
ACWV
$3.33B
| $3.11M | ﹤0.01% |
46,460
-318
| -0.7% | -$22K |
|
|
SIOX
1225
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $3.1M | ﹤0.01% |
30,049
+674
| +2% | +$79K |
|
Similar funds
BIM
BJ
IC
EAM
MFS
CIM
KAM
PFM
BlackRock Advisors's Q3 2015 Portfolio in Review
As of Q3 2015, BlackRock Advisors held 3,878 positions worth $93.3B, down 3% from $96.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BlackRock Advisors deployed $5.74B of net new capital in Q3 2015, opening 163 new positions and adding to 1,568 existing holdings. Its largest new stake was Allergan plc: 186,940 shares worth $176M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 20% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $195M trimmed.
- BlackRock Advisors's largest Q3 2015 buy was Allergan plc: 186,940 shares worth $176M.
- BlackRock Advisors added most to Apple in Q3 2015, an estimated $423M increase.
- BlackRock Advisors's biggest Q3 2015 reduction was Vertex Pharmaceuticals, cutting an estimated $195M.
- BlackRock Advisors fully exited RECEPTOS INC COM STK (DE) in Q3 2015, selling an estimated $108M.
- BlackRock Advisors's ten largest holdings make up 15% of its $93.3B portfolio in Q3 2015.
- BlackRock Advisors opened 163 new positions and closed 111 in Q3 2015.
- BlackRock Advisors's portfolio value fell 3% quarter-over-quarter to $93.3B.
Based on BlackRock Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.